Menu Search
Equities

Cochlear Ltd

COH:ASX

Cochlear Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)298.23
  • Today's Change5.21 / 1.78%
  • Shares traded89.40k
  • 1 Year change+13.52%
  • Beta0.7215
Data delayed at least 20 minutes, as of Nov 22 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Cochlear Ltd grew revenues 15.47% from 1.94bn to 2.24bn while net income improved 18.70% from 300.60m to 356.80m.
Gross margin75.84%
Net profit margin15.96%
Operating margin21.25%
Return on assets13.43%
Return on equity19.88%
Return on investment17.39%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Cochlear Ltd fell by 41.90m. However, the company earned 388.80m from its operations for a Cash Flow Margin of 17.39%. In addition the company used 105.70m on investing activities and also paid 323.80m in financing cash flows.
Cash flow per share6.72
Price/Cash flow per share44.20
Book value per share28.10
Tangible book value per share21.22
More ▼

Balance sheet in AUDView more

Cochlear Ltd has a Debt to Total Capital ratio of 11.69%, a higher figure than the previous year's 9.30%.
Current ratio2.30
Quick ratio1.68
Total debt/total equity0.1324
Total debt/total capital0.1169
More ▼

Growth rates in AUD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 24.24% and 19.01%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.21%
Div growth rate (5 year)4.44%
Payout ratio (TTM)75.25%
EPS growth(5 years)2.52
EPS (TTM) vs
TTM 1 year ago		19.03
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.